Friday, October 9, 2026
28.5 C
Bengaluru

7 Transitions in Leadership for Indian Pharma Leaders

The rapid pace of change, which began in 2020 is unrelenting and ongoing. The high-stakes game has made many pharma leaders play defensive, instead of using the crisis to bring in the much-needed transformational changes.

Leaders continue to rely on the traditional time-tested strategies, so that they can avoid the embarrassment of ‘losing’ in this high-stakes game. Most prefer to keep doing something they know to do well. We all like to do what we are good at, and are comfortable with. Most leaders are happy to be ‘nest-building’ and remain in their comfort zones.

There are several research findings, suggesting that to make the transition successfully, leaders must navigate a tricky set of changes in their leadership focus and skills.

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

The Great Healthcare Dilemma: Who Will Own the Next Indian Hospital?

The next owner of an Indian hospital may not...

Indian Pharma’s Three Deficits—and Three Potential Dividends

Indian pharma has already done the hard thing once. It...

Indian Pharma Is Two Industries Wearing One Label

Indian pharma is often discussed as one sector. In...

Why Is the World’s Pharmacy Failing to Protect Patients from Harm?

This MedicinMan Intelligence Report follows a disturbing trail—from Arun...

Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.

With over three decades of experience in the pharmaceutical...

Topics

spot_img

Related Articles

spot_imgspot_img